Avanos Medical, Inc. AVNS is well poised for growth on the back of robust performances by its Chronic Care and Pain Management segments as well as a strong product portfolio. However, competition ...

ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the publication of a large, randomized, multicentered clinical trial comparing the safety and ...

Avanos had disappointing Q1 results, with net sales at $191.7 million, down 2.9% year over year. It also posted a net loss of $500,000, compared to a net income of $5.4 million a year ago.

Avanos Medical ( (AVNS)) has shared an update. Avanos Medical, Inc. announced the retirement of CEO Joseph Woody, who will continue as a consultant until April 2025, and appointed Michael C ...